skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,153) Views

Editor in Chief Dr Roger M Pinder

1176-6328


Letter - Epi-inositol is ineffctive in Porsolt Forced Swim Test model of depression
Alona Shaldubina, Haim Einat, Yuly Bersudsky, RH Belmaker
Neuropsychiatric Disease and Treatment 2005, 1:189-190
28 February 2005


Letter - Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disoder patients
Kaplan Zeev, Matar Michael, Kamin Ram, Cohen Hagit
Neuropsychiatric Disease and Treatment 2005, 1:187-188
28 February 2005


Psychopathology and treatment responsiveness of patients with first-episode schizophrenia
Eva Cešková, Radovan Prikryl, Tomáš Kašpárek, Marta Ondrušová
Neuropsychiatric Disease and Treatment 2005, 1:179-185
18 February 2005


Increased serum interleukin-1β and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication
Andrea Schmitt, Thomas Bertsch, Heike Tost, Andrea Bergmann, Uwe Henning, Ansgar Klimke, Peter Falkai
Neuropsychiatric Disease and Treatment 2005, 1:171-177
18 February 2005


Impact of an activities-based adult dementia care program
Margaret Higgins, Kathleen Koch, Linda S Hynan, Sandra Carr, Kathleen Byrnes, Myron F Weiner
Neuropsychiatric Disease and Treatment 2005, 1:165-169
18 February 2005


The relationship between dementia severity and rest/activity circadian rhythms
Phil Gehrman, Matthew Marler, Jennifer L Martin, Tamar Shochat, Jody Corey-Bloom, Sonia Ancoli-Israel
Neuropsychiatric Disease and Treatment 2005, 1:155-163
18 February 2005


Changes in peripheral benzodiazepine receptors in patients with bipolar disorder
Donatella Marazziti, Bernardo Dell’Osso, Stefano Baroni, Irene Masala, Elena Di Nasso, Gino Giannaccini, Liliana Dell’Osso
Neuropsychiatric Disease and Treatment 2005, 1:151-154
18 February 2005


Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations
Kristin Brousseau, David Arciniegas, Susie Harris
Neuropsychiatric Disease and Treatment 2005, 1:145-149
18 February 2005


Conceptualization of depression in Parkinson’s disease
Jeffrey CL Looi, May Matias, Michelle J Ruzich
Neuropsychiatric Disease and Treatment 2005, 1:135-143
18 February 2005


Genetic and molecular aspects of spinocerebellar ataxias
Viktor Honti, László Vécsei
Neuropsychiatric Disease and Treatment 2005, 1:125-133
28 February 2005


Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model
Frasia Oosthuizen, Gregers Wegener, Brian H Harvey
Neuropsychiatric Disease and Treatment 2005, 1:109-123
18 February 2005


Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders
Stan Kutcher, Sarah J Brooks, David M Gardner, Bill Honer, Lili Kopala, Alain Labelle, Pierre Lalonde, Ashok Malla, Heather Milliken, Jorge Soni, Richard Williams
Neuropsychiatric Disease and Treatment 2005, 1:89-108
28 February 2005